- £75.59bn
- £90.25bn
- £32.67bn
Trump’s goal to split MMR vaccine could take a decade, experts say
Director/PDMR Shareholding
GSK India first-quarter profit rises on steady vaccine demand
Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US
Director/PDMR Shareholding
GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal
Brief: GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal
Media: GSK strikes AI deal with UK biotech Relation Therapeutics with the agreement valued up to $110 million - Bloomberg News
Press Digest: British Business - July 29
Press Digest: Financial Times - July 29
Brief: GSK Guides To More Than 31% Margin In 2026 - Conf Call
GSK plc reports results for the quarter ended June 30 - Earnings Summary
GSK to invest £400 million in Britain over three years as it ramps up R&D efforts (updated)
Brief: GSK CEO Says About 45% Of Savings Will Come From Better Procurement - Media Call
Brief: GSK-Hansoh Osteosarcoma drug succeeds in Phase III studies
GSK rises on cost-savings program, Q2 profit beat
GSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs (updated)
GSK Q2 sales beat analyst estimates on specialty medicines growth
New GSK flagship R&D centre in Cambridge